Celebrating World Antimicrobial Awareness week!

Home - Antimicrobial

Celebrating World Antimicrobial Awareness week!

It’s World Antimicrobial Awareness week!

Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites resist the effects of medications, making common infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become increasingly difficult or impossible to treat.

Randox want to take part in the global campaign that is celebrated annually to improve awareness and understanding of Antimicrobial. We have interviewed one of our Molecular specialists, Dr Dwaine Vance on how our revolutionary Randox products aid in the fight against AMR.

What threat does AMR present to the health care environment?

In a worse-case scenario the increasingly worrying levels of AMR globally will have a significant negative effect on healthcare. Without effective antimicrobials to treat a wide arrange of infectious diseases, people will be more likely to get ill, be unresponsive to medications, which in turn will result in longer hospital stays, increased economic burden, lower levels of quality of life and ultimately poorer prognosis including elevated levels of morbidity and mortality.

 

How does Randox help in the fight against AMR?

Randox have developed and continue to develop infectious disease tests to detect a wide-range infectious disease. Randox have also included resistance gene markers within these molecular-based PCR tests to determine if an infection is sensitive or resistance to certain antimicrobials.

In addition to diagnostic tests, Randox also supply quality control materials such as third-party molecular controls and external quality assessment schemes that are used in molecular microbiology laboratories to ensure their PCR tests are working accurately and robustly. This means that labs can provide the correct information to clinicians that is vitally important to determine what antibiotic therapy is prescribed to the patient.

 

Can you tell us about any exciting developments in Randox?

Randox are continuously investing and reinvesting in our Molecular Research and Development departments. We have recently released a molecular point of care test that can discriminate between MRSA and MSSA. This means that sufficient isolation and correct primary treatment can be provided to the patient in a timelier fashion. We are in the process of releasing a UTI test that can detect over 20 UTI-related bacterial infections. In addition to these pathogens, this test also determines if the pathogens detected are resistant to commonly used antibiotics such as Trimethoprim or Vancomycin.

Furthermore, Randox are releasing an immunoassay-based point of care machine called the VerasSTAT, which includes tests for CRP and MxA biomarkers. These biomarkers are released into the bloodstream during infection as part of the body’s immune response. CRP and MxA can assist the clinician in determining if an infection is of bacterial or viral origin.

 

What measures do you think we can take to prevent the spread of AMR?

Improved personal hygiene and sanitation will reduce transmission of infectious diseases within the global population. The development of more innovative and more easily accessible antibiotics, as well as improved antibiotic stewardship within clinical settings will also help slow down the alarming rates of AMR globally. Most importantly, the creation of new syndromic style testing panels, like the tests currently provided by Randox will undoubtedly improve the clinical outcome for patients who are have an infectious disease.

We are urging the public to help raise awareness of antimicrobial resistance. Randox is committed to the ongoing development of products and services as well as our research into numerous disease areas to improve health worldwide.

To find out more, visit- www.randox.com or email us- market@randox.com

Continue reading…


Randox showcases most advanced dairy screening test on market at World Dairy Summit

Improving global dairy standards is the focus for Randox Food Diagnostics, which is demonstrating its latest advancement – the ‘InfiniPlex for Milk’ – at the 2017 World Dairy Summit. Over 1000 international delegates are expected to attend the event being held in Belfast’s Waterfront Hall between 30th October to 3rd November.

With maintaining consumer confidence in the safety and integrity of dairy products featuring as one of the key topics at this year’s summit, the Northern Ireland-based company is keen to showcase how it can help producers get an edge in the market through ensuring food safety.

At the International Dairy Foundation’s annual conference event Randox Food will be showcasing the InfiniPlex, an innovative system which tests for 130 restricted drugs from one sample, such as antibiotics, non-steroidial anti-inflammatory and anti-parasitic drug residues.  This is the most comprehensive array on the market and achieves 98% compliance with EU regulations.

The Infiniplex also identifies a number of drug compounds which are not on the EU’s regulated list but which are unsuitable for human consumption. Using this multiplex system ensures that any Randox-tested dairy product will be the safest on the shelf.

Dr FitzGerald, Founder and Managing Director of Randox Laboratories, commented;

“It is our aim to ensure that dairy producers have access to the latest and most comprehensive milk safety screening technologies. The Infiniplex for Milk is the world’s first screening technology that ensures dairy processors are compliant with regulations. By meeting its complex needs, InfiniPlex is changing the face of the global dairy industry.”

David Ferguson, Global Business Manager for Randox Food Diagnostics, added;

“Standard industry practice means the primary residues for which screening is carried out is usually limited to two certain varieties of antibiotics. The InfiniPlex for Milk provides a unique insight into the specific combination of drug compounds detected in a single sample offering drug discrimination that allows the user to see what commercially available drug was administered at animal level. Using our multiplex testing offers the global milk industry the most comprehensive product for the analysis of veterinary drug residues in food, protecting the food industry and the consumer.”

The International Dairy Federation World Dairy Summit takes place in the Waterfront Hall. Randox Food Diagnostics can be found at Booth 5.

For further information about Randox Food Diagnostics milk testing, please visit: http://www.randoxfood.com/Matrices/Milk

For any further questions please contact Randox PR by phoning 028 9445 1016 or emailing RandoxPR@randox.com


Randox Food Diagnostics harnessing science of antibiotic screening to ensure safer honey

Global leader in food screening technology, Randox Food Diagnostics have developed a range of pioneering honey quality tests which are being adopted by apiculturists across the world to ensure the safety and quality of their produce.

The array of tests, developed by the Antrim-based firm, are being showcased this week at the world’s largest apiculture meeting, the Apimondia International Conference, being held in Istanbul, Turkey from September 29th to October 4th.

The company hopes to highlight to consumers and producers about the importance of food safety, and in particular the dangers of antibacterial residue in food. Scientists have warned that antibiotics used in food production, are passing through the food chain to consumers and therefore contributing to the rise in infections caused by antibiotic-resistant bacteria.

Randox Founder and Managing Director, Dr Peter FitzGerald, commented;

“As a company committed to supporting the fight against antibiotic resistance we must continue to drive awareness amongst producers and consumers alike.

 “We are working closely with industry to promote a responsible approach to antibiotic use in food production and we hope that by working with some of the biggest names in the apiculture market, other honey producers will see the benefits of being able to offer their customers complete consumer confidence in a high quality, and importantly, safe product.”

 At Apimondia 2017 Randox Food Diagnostics will showcase a range of major technological advancements including the firm’s Antimicrobial Array 1 Ultra, Antimicrobial Array II Plus and Antimicrobial Array V. Thanks to Randox’s patented Biochip Array Technology, these testing panels can simultaneously screen for multiple antibiotics that are sprayed on beehives to ensure the safety of the colony, from only one sample of the produce.

Randox Food’s Antimicrobial Arrays join the company’s already extensive menu of honey screening tests, including its test for Hydroxymethylfurfural (HMF), a test for an organic compound produced by dehydration of sugars, which can be indicative of overheating, poor storage conditions or aged honey.  The test was recently validated by leading South American honey producer Geomiel, which credited Randox Food for delivering an immediate improvement in the quality of its honey products.

David Ferguson, Global Business Manager for Randox Food Diagnostics, commented;

 “We welcome the fact that so many of the world’s leading producers, including Geomiel, have embraced our vision of continuously improving testing standards.

“We have invested a lot in simplifying the process of conducting multiple tests, and consolidating this onto one unique biochip is a cost-effective way for the honey industry to maintain and improve standards. Apimondia 2017 attendees will be offered a complete testing bundle – including our popular analysers, the Randox Evidence Investigator and RX misano, to enable them to test for antibiotics and assess quality in one easy-to-manage system.

“Another unique feature of what we offer here at Randox Food Diagnostics is our ever-expanding test menu. The RX misano for example has a customisable test menu which allows clients to upload new parameters using USB, ensuring access to the most up-to-date tests on the market.

“We will be inviting Apimondia guests to learn more about the upcoming launch of our new pesticide tests, which will provide multiple results for the world’s most prevalent pesticides, such as Amitraz, Acetamiprid, Carbofuran, Carbaryl, and Paraquar. We remain committed to supporting food producers by providing them with the newest and highest quality tests.”

For further information about Randox Food Diagnostics honey testing, please visit: http://www.randoxfood.com/Matrices/Honey

For any further questions please contact Randox PR by phoning 028 9445 1016 or emailing RandoxPR@randox.com


Antimicrobial Quality Control III

Therapeutic Drug Quality Control

Multi-analyte quality control containing values for 5 different antimicrobial agents.

Features & Benefits

  • Lyophilised for enhanced stability
  • Stable to expiry date at 2oC – 8oC
  • Reconstituted stability of 28 days at 2oC – 8oC
  • Assayed values available  for Randox Biochip systems
DescriptionSizeAnalytesCat No
Antimicrobial Control III3 x 1ml5AMC5036

Analytes

  • 5-Methylmorpholino-3-amino-2-oxazolidinone (AMOZ)
  • 1-Amino hydantoin hydrochloride (AHD)
  • 3-Amino-2-oxazoilidinone (AOZ)
  • Semicarbazine (SEM)
  • Chloramphenicol

Antimicrobial Quality Control II

Therapeutic Drug Quality Control

A multi-analyte quality control supplied with values for 6 different antimicrobial agents used extensively in veterinary medicine.

Features & Benefits

  • Lyophilised for enhanced stability
  • Stable to expiry date at 2oC – 8oC
  • Reconstituted stability of 24 hours at 2oC – 8oC or 2 weeks at -20°C
  • Assayed values available for Randox Biochip systems
DescriptionSizeAnalytesCat No
Antimicrobial II control3 x 1ml6AMC5035

Analytes

  • Tetracyclines (generic)
  • Tylosin
  • Thiamphenicol
  • Quinolones (generic)
  • Streptomycin
  • Ceftiofur